Rajan Gunesh, Tavora-Vieira Dayse, Baumgartner Wolf-Dieter, Godey Benoit, Müller Joachim, O'Driscoll Martin, Skarzynski Henryk, Skarzynski Piotr, Usami Shin-Ichi, Adunka Oliver, Agrawal Sumit, Bruce Iain, De Bodt Marc, Caversaccio Marco, Pilsbury Harold, Gavilán Javier, Hagen Rudolf, Hagr Abdulrahman, Kameswaran Mohan, Karltorp Eva, Kompis Martin, Kuzovkov Vlad, Lassaletta Luis, Yongxin Li, Lorens Artur, Manoj Manikoth, Martin Jane, Mertens Griet, Mlynski Robert, Parnes Lorne, Pulibalathingal Sasidharan, Radeloff Andreas, Raine Christopher H, Rajeswaran Ranjith, Schmutzhard Joachim, Sprinzl Georg, Staecker Hinrich, Stephan Kurt, Sugarova Serafima, Zernotti Mario, Zorowka Patrick, Van de Heyning Paul
a Department of Otolaryngology, Head and Neck Surgery , School of Surgery, University of Western Australia , Murdoch , Australia.
b Medizinische Universität Wien, Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten , Wien , Austria.
Cochlear Implants Int. 2018 Jan;19(1):1-13. doi: 10.1080/14670100.2017.1379933. Epub 2017 Oct 26.
To provide multidisciplinary cochlear implant teams with a current consensus statement to support hearing preservation cochlear implantation (HPCI) in children, including those children with symptomatic partial deafness (PD) where the intention is to use electric-acoustic stimulation (EAS). The main objectives are to provide guidelines on who is a candidate, how to assess these children and when to implant if Med-El Flex electrode arrays are chosen for implantation.
The HEARRING group reviewed the current evidence and practice regarding the management of children to be considered for HPCI surgery emphasizing the assessment needed prior to implantation in order to demonstrate the benefits in these children over time. The consensus statement addresses following three key questions: (1) Should these children be treated? (2) How to identify these children? (3) How to manage these children?
The HEARRING group concludes that irrespective of the degree of residual hearing present, the concepts of hearing and structure preservation should be applied in every child undergoing cochlear implantation and that HPCI is a safe and reliable treatment option. Early detection and multidisciplinary assessment are key to the identification of children with symptomatic PD, these children should undergo HPCI as early as possible.
为多学科人工耳蜗植入团队提供一份当前的共识声明，以支持儿童听力保留人工耳蜗植入（HPCI），包括那些有症状的部分性耳聋（PD）儿童，其目的是采用电声刺激（EAS）。主要目的是提供关于哪些人是候选者、如何评估这些儿童以及如果选择Med-El Flex电极阵列进行植入何时进行植入的指导原则。
HEARRING小组回顾了目前关于考虑进行HPCI手术的儿童管理的证据和实践，强调植入前所需的评估，以便证明随着时间推移这些儿童能从中获益。该共识声明涉及以下三个关键问题：（1）这些儿童是否应接受治疗？（2）如何识别这些儿童？（3）如何管理这些儿童？
HEARRING小组得出结论，无论存在何种程度的残余听力，听力和结构保留的概念都应适用于每一位接受人工耳蜗植入的儿童，并且HPCI是一种安全可靠的治疗选择。早期检测和多学科评估是识别有症状PD儿童的关键，这些儿童应尽早接受HPCI。
